Published in
Elsevier, Cancer Letters, (400), p. 219-222
DOI: 10.1016/j.canlet.2016.10.047
Links
Tools
Metronomic chemotherapy in head and neck cancer
Journal article published in 2016 by
Francesca De Felice 
,
Ilaria Benevento,
Angela Musella,
Daniela Musio,
Vincenzo Tombolini
,
Ilaria Benevento,
Angela Musella,
Daniela Musio,
Vincenzo Tombolini
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
Head neck cancer (HNC) is generally treated with a multimodality approach. Loco-regional-distant control is often worst, due to the advantage stage disease at diagnosis and the optimal treatment option remains an unresolved issue. Metronomic chemotherapy (MCHT) is an emerging therapeutic option in clinical oncology and it may prove useful in HNC patients.